Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors

Transfusion

Volumn 54, Issue 11, 2014, Pages 2833-2841

  Engle, Ronald E ^a   Bukh, Jens ^b   Alter, Harvey J ^c,d   Emerson, Suzanne U ^a   Trenbeath, Joni L ^c,d   Nguyen, Hanh T ^a   Brockington, Alicia ^a   Mitra, Tanaji ^a   Purcell, Robert H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; OPEN HEART SURGERY; PHYLOGENETIC TREE; POSTTRANSFUSION HEPATITIS; PROSPECTIVE STUDY; SCREENING; SEROCONVERSION; BLOOD TRANSFUSION; CLINICAL TRIAL; FOLLOW UP; HEPACIVIRUS; MIDDLE AGED; RETROSPECTIVE STUDY; TIME; TRANSMISSION;

ADULT; AGED; BLOOD TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84912126717     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12682     Document Type: Article

References (44)

1. MacCollum FO,. Homologous serum hepatitis. Lancet 1947; 2: 691.
2. Allen JG, Sayman WA,. Serum hepatitis from transfusions of blood. Epidemiologic study. JAMA 1962; 180: 1079-1085.
3. Grady GF, Chalmers TC,. Risk of post-transfusion viral hepatitis. N Engl J Med 1964; 271: 337-342.
4. Kunin CM,. Serum hepatitis from whole blood: incidence and relation to source of blood. Am J Med Sci 1959; 237: 293-303.
5. Mirick GS, Ward R, McCollum RW,. Modification of post-transfusion hepatitis by gamma globulin. N Engl J Med 1965; 273: 59-65.
6. Shimizu Y, Kitamoto O,. The incidence of viral hepatitis after blood transfusions. Gastroenterology 1963; 44: 740-744.
7. Hampers CL, Prager D, Senior JR,. Post-transfusion anicteric hepatitis. N Engl J Med 1964; 271: 749-754.
8. Karmen A, Wroblewski F, Ladue JS,. Transaminase activity in human blood. J Clin Invest 1955; 34: 126-131.
9. Senior JR,. Reflections upon the incidence of posttransfusion hepatitis in various parts of the world. Am J Gastroenterol 1968; 49: 298-303.
10. Aach RD, Alter HJ, Hollinger FB, et al. Risk of transfusing blood containing antibody to hepatitis-B surface antigen. Lancet 1974; 2: 190-193.
11. Gocke DJ,. A prospective study of posttransfusion hepatitis. The role of Australia antigen. JAMA 1972; 219: 1165-1170.
12. Grady GF, Bennett AJ,. Risk of posttransfusion hepatitis in the United States. A prospective cooperative study. JAMA 1972; 220: 692-701.
13. Knodell RG, Conrad ME, Ginsberg AL, et al. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet 1976; 1: 557-561.
14. Seeff LB, Zimmerman HJ, Wright EC, et al. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology 1977; 72: 111-121.
15. Walsh JH, Purcell RH, Morrow AG, et al. Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA 1970; 211: 261-265.
16. Alter HJ, Holland PV, Morrow AG, et al. Clinical and serological analysis of transfusion-associated hepatitis. Lancet 1975; 2: 838-841.
17. Alter HJ, Holland PV, Purcell RH, et al. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med 1972; 77: 691-699.
18. Alter HJ, Purcell RH, Holland PV, et al. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981; 246: 630-634.
19. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-1500.
20. Holland PV, Walsh JH, Morrow AG, et al. Failure of Australia antibody to prevent post-transfusion hepatitis. Lancet 1969; 2: 553-555.
21. Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488-495.
22. Purcell RH, Walsh JH, Holland PV, et al. Seroepidemiological studies of transfusion-associated hepatitis. J Infect Dis 1971; 123: 406-413.
23. Allen JG, Sykes C, Enerson DM, et al. Homologous serum jaundice and its relationship to methods of plasma storage. J Lab Clin Med 1950; 36: 796-797.
24. Sayman WA, Gauld RL, Star SA, et al. Safety of liquid plasma: a statistical appraisal. J Am Med Assoc 1958; 168: 1735-1739.
25. Redeker AG, Hopkins CE, Jackson B, et al. A controlled study of the safety of pooled plasma stored in the liquid state at 30-32 C for six months. Transfusion 1968; 8: 60-64.
26. Committee on Plasma and Plasma Substitutes of the Division of Medical Sciences NRC. Statement on normal (whole, pooled) human plasma prepared by Committee on Plasma and Plasma Substitutes of the Division of Medical Sciences, National Research Council. Transfusion 1968; 8: 57-59.
27. Engle RE, Yu C, Emerson SU, et al. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002; 40: 4576-4580.
28. Yu C, Engle RE, Bryan JP, et al. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol 2003; 10: 579-586.
29. Engle RE, Russell RS, Purcell RH, et al. Development of a TaqMan assay for the six major genotypes of hepatitis C virus: comparison with commercial assays. J Med Virol 2008; 80: 72-79.
30. Payette PJ, Ma X, Weeratna RD, et al. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge. Intervirology 2006; 49: 144-151.
31. Shukla P, Nguyen HT, Torian U, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011; 108: 2438-2443.
32. Yu C, Boon D, McDonald SL, et al. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol 2010; 84: 11264-11278.
33. Corbet S, Bukh J, Heinsen A, et al. Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol 2003; 41: 1091-1100.
34. Dorsey KA, Moritz ED, Steele WR, et al. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010. Transfusion 2013; 53: 1250-1256.
35. Bigger CB, Brasky KM, Lanford RE,. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001; 75: 7059-7066.
36. Su AI, Pezacki JP, Wodicka L, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 2002; 99: 15669-15674.
37. Dienes HP, Purcell RH, Popper H, et al. The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees. J Hepatol 1990; 10: 77-84.
38. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
39. Matsumoto A, Yeo AE, Shih JW, et al. Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology 1999; 30: 283-288.
40. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a "nonhyperendemic" country. Transfus Med 2006; 16: 79-83.
41. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48: 1368-1375.
42. Davern TJ, Chalasani N, Fontana RJ, et al., Drug-Induced Liver Injury Network. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141: 1665-72 e1-9.
43. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997; 94: 9860-9865.
44. Fu P, Myhre B,. Chemical analysis of a 30-year-old bottle of lyophilized plasma. Transfusion 1977; 17: 73-74.